Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma AidsDHA:PHARMAID -2.55%73 Dividend Yield % is 0.47% as of Jul. 17, 2026, which is 27% below its 10-year median of 0.64. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 325 Medical Devices & Instruments companies, Pharma Aids ranks worse than 88.92% on this metric.
As of today (2026-07-17), the Trailing Annual Dividend Yield of Pharma Aids is 0.47%.
The historical rank and industry rank for Pharma Aids's Dividend Yield % or its related term are showing as below:
DHA:PHARMAID'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.13 Med: 0.64 Max: 1.34
Current: 0.47
During the past 13 years, the highest Dividend Yield of Pharma Aids was 1.34%. The lowest was 0.13%. And the median was 0.64%.
DHA:PHARMAID's Dividend Yield % is ranked worse than 88.92% of 325
companies
in the Medical Devices & Instruments industry
Industry Median: 1.98
vs DHA:PHARMAID: 0.47
During the past 12 months, Pharma Aids's average Dividends Per Share Growth Rate was 20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -20.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -21.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -1.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Pharma Aids was 26.00% per year. The lowest was -41.50% per year. And the median was 6.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Pharma Aids (DHA:PHARMAID) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Pharma Aids's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:PHARMAID vs ISRG, BDX, MDLN: Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Pharma Aids's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Aids Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Pharma Aids's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Pharma Aids Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
BDT 3.000000
2025-12-08
2025-12-07
2026-02-02
Cash Dividend
annually
BDT:BDT 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Pharma Aids's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
3
/
644.70
=
0.47 %
Current Share Price is BDT644.70. Pharma Aids's Dividends per Share for the trailing twelve months (TTM) ended in Today is BDT3.
Pharma Aids's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
3
/
644.70
=
0.47 %
Current Share Price is BDT644.70. Pharma Aids's Dividends per Share for the forward twelve months is calculated as BDT3 * 1 = BDT3.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Aids (DHA:PHARMAID) has a Dividend Yield % of 0.47% as of Jul. 17, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Pharma Aids and its competitors. This is 27% below median its historical median of 0.64. Over the past decade, Pharma Aids' Dividend Yield % has ranged from 0.13 to 1.34. According to the industry distribution chart, Pharma Aids ranks #289 out of 325 companies in the Medical Devices & Instruments industry, placing it in the top 88.9%.
Is Pharma Aids' Dividend Yield % too high?
Pharma Aids' current Dividend Yield % of 0.47% is 27% below median its 10-year median of 0.64. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 1.34. The Medical Devices & Instruments industry median Dividend Yield % is 1.98. Pharma Aids' value of 0.47% is 76.3% below this industry median. Based on the distribution chart, Pharma Aids ranks #289 out of 325 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Pharma Aids ranks #289 out of 325 companies for Dividend Yield %. This places Pharma Aids in the lower half of its industry. The industry median Dividend Yield % is 1.98. Pharma Aids' value of 0.47% is 76.3% below this benchmark. Historically, Pharma Aids' own Dividend Yield % has ranged from 0.13 to 1.34 over the past decade. While the company's 10-year median is 0.64 vs. the industry median of 1.98, Pharma Aids has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Aids's current Dividend Yield % of 0.47% is 76.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Pharma Aids and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Aids's current Dividend Yield % is 0.47%, which is 27% below median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current Dividend Yield % is 0.47%, which is 27% below median its 10-year median of 0.64 and 76.3% below the Medical Devices & Instruments industry median of 1.98. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current Dividend Yield % is 0.47% as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued.
The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56.
GuruFocus considers Pharma Aids to be Modestly Undervalued.
Key valuation signals for DHA:PHARMAID:
Dividend Yield %: 0.47% (27% below median its 10-year median of 0.64)
GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
Industry Position: 76.3% below the Medical Devices & Instruments median (#289 of 325)
No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score
Get the complete analysis for DHA:PHARMAID
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:PHARMAID has been successfully added to your 
